427 related articles for article (PubMed ID: 29364519)
61. Gene Editing With TALEN and CRISPR/Cas in Rice.
Bi H; Yang B
Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
[TBL] [Abstract][Full Text] [Related]
62. Detection and Quantification of HDR and NHEJ Induced by Genome Editing at Endogenous Gene Loci Using Droplet Digital PCR.
Miyaoka Y; Mayerl SJ; Chan AH; Conklin BR
Methods Mol Biol; 2018; 1768():349-362. PubMed ID: 29717453
[TBL] [Abstract][Full Text] [Related]
63. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
64. Strategies for generation of mice via CRISPR/HDR-mediated knock-in.
Mathew SM
Mol Biol Rep; 2023 Apr; 50(4):3189-3204. PubMed ID: 36701041
[TBL] [Abstract][Full Text] [Related]
65. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
[TBL] [Abstract][Full Text] [Related]
66. Rates of homology directed repair of CRISPR-Cas9 induced double strand breaks are lower in naïve compared to primed human pluripotent stem cells.
Dodsworth BT; Hatje K; Meyer CA; Flynn R; Cowley SA
Stem Cell Res; 2020 Jul; 46():101852. PubMed ID: 32521498
[TBL] [Abstract][Full Text] [Related]
67. Efficient and allele-specific genome editing of disease loci in human iPSCs.
Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
[TBL] [Abstract][Full Text] [Related]
68. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
69. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
[TBL] [Abstract][Full Text] [Related]
70. Therapeutic Genome Editing by CRISPR/Cas9-Mediated Strategy to Cure Genetic Disorders in Humans: Guide for Molecular Surgeons.
Ergoren MC; Idlibi R
Crit Rev Eukaryot Gene Expr; 2019; 29(5):387-399. PubMed ID: 32421996
[TBL] [Abstract][Full Text] [Related]
71. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
72. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
73. Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.
Umbach A; Maule G; Kheir E; Cutarelli A; Foglia M; Guarrera L; Fava LL; Conti L; Garattini E; Terao M; Cereseto A
Stem Cell Res Ther; 2022 Sep; 13(1):440. PubMed ID: 36056433
[TBL] [Abstract][Full Text] [Related]
74. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
75. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
[TBL] [Abstract][Full Text] [Related]
76. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
77. Decorating chromatin for enhanced genome editing using CRISPR-Cas9.
Chen E; Lin-Shiao E; Trinidad M; Saffari Doost M; Colognori D; Doudna JA
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2204259119. PubMed ID: 36459645
[TBL] [Abstract][Full Text] [Related]
78. Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone H2A-K15 ubiquitination.
Bashir S; Dang T; Rossius J; Wolf J; Kühn R
BMC Biotechnol; 2020 Oct; 20(1):57. PubMed ID: 33097066
[TBL] [Abstract][Full Text] [Related]
79. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
80. 'Cold shock' increases the frequency of homology directed repair gene editing in induced pluripotent stem cells.
Guo Q; Mintier G; Ma-Edmonds M; Storton D; Wang X; Xiao X; Kienzle B; Zhao D; Feder JN
Sci Rep; 2018 Feb; 8(1):2080. PubMed ID: 29391533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
